FDA Drug recall D-0769-2022
Preferred Pharmaceuticals, Inc
- FDA Drug
- Class II
- terminated
- Published 2022-04-20
On 2022-04-20 the FDA classified a Class II recall of Preferred Pharmaceuticals, Inc by Preferred Pharmaceuticals, citing out of specification results observed in dissolution during long term stability testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0769-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2022-03-28 |
| Published | 2022-04-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Preferred Pharmaceuticals |
| Distribution | US |
Product
Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prevacid, 90-Count Bottle, Manufacturer: Dr Reddy's Laboratories Limited, NDC 68788-6390-09
Reason
Out of specification results observed in dissolution during long term stability testing.
Identifiers
| code_info | Lots: H0221R, D3021T, D2221J, D1321X, Exp.12/31/2023. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0769-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.